Colgate-Palmolive (NYSE:CL) Stock Position Raised by NatWest Group plc

NatWest Group plc boosted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 138.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 109,424 shares of the company's stock after purchasing an additional 63,511 shares during the quarter. Colgate-Palmolive makes up 3.4% of NatWest Group plc's portfolio, making the stock its 13th biggest holding. NatWest Group plc's holdings in Colgate-Palmolive were worth $11,359,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Diversify Advisory Services LLC acquired a new stake in Colgate-Palmolive during the first quarter worth about $911,000. TD Asset Management Inc increased its stake in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock worth $103,969,000 after acquiring an additional 26,987 shares during the last quarter. Empowered Funds LLC increased its stake in Colgate-Palmolive by 277.3% during the first quarter. Empowered Funds LLC now owns 33,082 shares of the company's stock worth $2,979,000 after acquiring an additional 24,314 shares during the last quarter. M&G Plc acquired a new stake in Colgate-Palmolive during the first quarter worth about $3,812,000. Finally, Sei Investments Co. increased its stake in Colgate-Palmolive by 41.5% during the first quarter. Sei Investments Co. now owns 598,639 shares of the company's stock worth $53,901,000 after acquiring an additional 175,445 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock traded up $0.43 on Friday, reaching $100.46. 4,462,393 shares of the company were exchanged, compared to its average volume of 4,340,555. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The company's 50-day moving average is $103.46 and its two-hundred day moving average is $97.46. The firm has a market cap of $82.42 billion, a price-to-earnings ratio of 31.81, a P/E/G ratio of 3.54 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $71.46 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion for the quarter, compared to analysts' expectations of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business's quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. As a group, research analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.99%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive's dividend payout ratio is currently 63.29%.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Piper Sandler initiated coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target for the company. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and upped their target price for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Bank of America upped their target price on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Wednesday, July 10th. Finally, Wells Fargo & Company downgraded Colgate-Palmolive from an "equal weight" rating to an "underweight" rating and set a $100.00 target price for the company. in a research report on Monday, September 16th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $106.00.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares of the company's stock, valued at approximately $529,729.24. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last three months. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.